埃尔赛义德援引《尝试权法案》称共和党人也认为治疗决策应由医生做出
2026年9月12日 美国东部时间上午10:43 / 福克斯新闻
阿卜杜勒·埃尔赛义德为儿童变性诊疗辩护时吹嘘“实打实的”行医资质
这位密歇根州民主党联邦参议院候选人称，医疗决策应该留给患者、父母和医生——这些人都上过“实打实的”医学院。
您现在可以收听福克斯新闻的文章了！
收听本文
5分钟
密歇根州民主党联邦参议院候选人阿卜杜勒·埃尔赛义德表示，政府不应限制变性手术，并称像他这样“实打实的”医生应该有权为患者的治疗方案自行做出判断。
此番言论出自埃尔赛义德周五在密歇根州立大学举行的竞选集会，这位前底特律卫生部门负责人在会上回应了一名学生关于保护变性手术的提问。自参选以来，埃尔赛义德一直标榜自己是一名“医生”，并表示如果当选，他将成为50年来首位以医生身份任职的民主党参议员。但福克斯新闻数字频道此前曾报道，埃尔赛义德从未在密歇根州或纽约州持有行医执照。
“我上过实打实的医学院，和我一起毕业的所有人也都上过实打实的医学院，”埃尔赛义德说，“之后……他们还完成了实打实的住院医师培训，对吧？有些人还完成了实打实的专科医师培训。他们为了提供实打实的医疗服务，参加了实打实的考试。”
民主党参议院候选人“医生”竞选宣传遭抨击，执照记录暴露关键空白
“当患者寻求治疗时，他们就是患者想要咨询的专家，”埃尔赛义德继续说道，“关于何种医疗服务是必要的决策，应该由患者——如果患者未满18岁，则由其父母——和他们的医生共同做出。仅此而已。”
此番言论发表之际，特朗普政府在限制未成年人接受“性别抗拒”诊疗方面取得了重大进展，这类诊疗包括激素疗法和变性手术。
本周早些时候，司法部宣布西奈山医院已与德克萨斯儿童医院、克利夫兰诊所基金会、康涅狄格儿童医院等其他医院一道，在与特朗普政府达成协议后，暂停为儿童实施变性手术。
特朗普政府抨击“实验性”疗法，医疗补助计划终止对儿童变性手术的资助
埃尔赛义德将“全民医保”——即政府运营的医疗体系——作为其竞选活动的主要卖点；他表示，即便政府将承担医疗费用，也不应干预医生针对患者治疗方案的决策。
“我认为政府无权决定在何种情况下、出于何种原因提供何种医疗服务，”埃尔赛义德说，“在我看来，这就是我们决定如何制定医疗决策的标准。”
专家指出，社会主义者避而不谈的全民医保权衡问题
“不是由政府规定你能做什么或不能做什么，而是由患者和/或其父母（如果患者未满18岁）以及他们的医疗服务提供者共同决定。这才是最重要的，”埃尔赛义德继续说道，“关于我们谈论生殖权利和跨性别群体医疗保健时的相关说法，有很多不实信息。但归根结底，最关键的环节就是诊室里患者和医疗服务提供者之间的互动，这才是我们应该围绕的核心。”
埃尔赛义德辩称，共和党人认同他的观点，即治疗决策应由患者和医生共同做出，并援引了《尝试权法案》，该法案允许绝症患者在穷尽所有其他治疗选择后，尝试尚未获得美国食品药品监督管理局批准的实验性药物疗法。
“因为保守派长期以来一直在为一项名为《尝试权》的立法而斗争，其核心思想是政府不能告诉你不能使用某种药物，”埃尔赛义德说。
特朗普政府调查可能颠覆广泛使用的跨性别青年治疗指南
“所以他们认同医疗决策应该由患者本人和他们的医疗服务提供者共同做出。仅此而已。那我们就沿用这个标准，坚守这个标准，确保政府无权告诉你你能或不能用自己的生命做什么，”埃尔赛义德说。
然而，关于通过“跨性别”激素和青春期阻断剂来治疗性别焦虑症的疗效，相关研究十分有限。
世界跨性别健康专业协会（WPATH）的指南被美国儿科学会等主流医学协会采用，目前正面临联邦贸易委员会（FTC）的诉讼，指控该协会的指南误导家长，称变性手术“存在医疗共识和医疗必要性”，且“安全有效”。
联邦贸易委员会指控WPATH未披露部分手术相关的副作用，例如患者在使用“跨性别”激素后出现尿失禁、勃起疼痛、情绪障碍、骨盆疼痛和阴道疼痛等症状。
点击此处下载福克斯新闻应用程序
与此同时，那些实行公费医疗的国家已经对未成年人寻求变性手术施加了限制。在英国，国民保健署于今年3月暂停为16至17岁青少年提供“跨性别”激素疗法，理由是相关研究“证据非常薄弱”，不足以支持该疗法。
该国此前已经禁止16岁以下儿童接受变性激素治疗。
埃尔赛义德的办公室未立即回应福克斯新闻数字频道就其行医资质提出的置评请求。
伊莱恩·马伦是福克斯新闻数字频道和福克斯商业频道的撰稿人，报道全国政治新闻。
https://www.foxnews.com/video/6404973816112
blob:https://www.foxnews.com/3a0d4f57-e564-4368-be7e-216b30dd36ee
Abdul El-Sayed touts ‘whole a–’ medical credentials while defending sex changes for children
El-Sayed pointed to the Right to Try Act to argue Republicans also believe treatment decisions belong with doctors
September 12, 2026 10:43am EDT / Fox News
Abdul El-Sayed touts ‘whole a–’ medical credentials to defend child sex change procedures
The Michigan Democratic U.S. Senate candidate argued that medical decisions should be left to patients, parents and doctors, who went to “whole a–” medical school.
NEW You can now listen to Fox News articles!
Listen to this article
5 min
Michigan Democratic U.S. Senate candidate Abdul El-Sayed said the government should not restrict sex changes, arguing that “whole a–” doctors like himself should be allowed to make their own determinations for patients’ treatment plans.
The remarks came during El-Sayed’s Friday rally held at Michigan State University, during which the former Detroit Health Department head responded to a student’s question about protecting sex changes. Since launching his campaign, El-Sayed has flaunted that he is a “physician” and, if elected, he would be the first doctor to serve as a Democratic senator in 50 years. However, Fox News Digital previously reported El-Sayed has never held a medical license in Michigan or New York.
“I went to a whole a– medical school, everybody I graduated with also went to whole a– medical school,” El-Sayed said. “And then… they went to whole a– residency. Right? And some of them went to whole a– fellowship. They took whole a– exams to provide whole a– healthcare.”
DEM SENATE HOPEFUL’S ‘PHYSICIAN’ CAMPAIGN PITCH UNDER FIRE AFTER LICENSE RECORDS REVEAL KEY GAPS
Abdul El-Sayed answers a question during a press conference at the Michigan Democratic Party State Endorsement Convention in Detroit on April 19, 2026. El-Sayed has never held a medical license in Michigan or New York.(Jose Juarez/AP Photo)
“They are the experts that a patient wants to see when they seek care,” El-Sayed continued. “And the decision about what healthcare is necessary ought to be held between a patient — and or their parents if they’re under the age of 18 — and their doctor. That’s it.”
The remarks come as the Trump administration has made major strides in restricting minors’ access to “sex-rejecting” procedures, which include hormone therapy and surgeries.
Earlier this week, the Justice Department announced that Mount Sinai had joined other hospitals, like Texas Children’s Hospital, the Cleveland Clinic Foundation and Connecticut Children’s Hospital, to halt sex change procedures for children after reaching an agreement with the Trump administration.
MEDICAID ENDS FUNDING FOR CHILD SEX-CHANGE PROCEDURES AS TRUMP ADMIN SLAMS ‘EXPERIMENTAL’ TREATMENTS
El-Sayed has made the promise of “Medicare-for-all” — government-run healthcare — as the major selling point of his campaign; he said that even though the government will be covering the bill, it needs to stay out of the doctor’s decisions about a patient’s treatment plan.
“I don’t think the government gets to have a say about what healthcare is provided in what circumstances and why,” El-Sayed said. “And to me, that is the standard on which we decide how we make healthcare decisions.”
THE MEDICARE FOR ALL TRADE-OFFS SOCIALISTS AREN’T TALKING ABOUT, ACCORDING TO EXPERTS
A protester holds a sign in support of sex changes for transgender children outside the U.S. Supreme Court in Washington, D.C., on June 18, 2025.(Anna Moneymaker/Getty Images)
“Not what the government says you can or can’t do, but what a patient and/or their parent, if they’re under 18, and their provider to decide. That’s the most important thing,” El-Sayed continued. “And there’s a lot of disinformation about us, what we’re talking about, when we talk about reproductive rights and when we’re talking about healthcare for the trans folks. But, in the end, the place where the rubber meets the rope is in that clinical room between a patient and a provider, and that to me is the center we should engage on.”
El-Sayed argued that Republicans agree with his belief that treatment decisions should be between a patient and their doctor, pointing to the Right to Try Act, which allows terminally ill patients to try experimental drug treatments that aren’t yet approved by the Food and Drug Administration after they have exhausted all other treatment options.
“Because conservatives fought for a very long time for this legislation called ‘Right to Try’ legislation, which is the idea that the government couldn’t tell you [that] you couldn’t have a certain medication,” El-Sayed said.
TRUMP ADMINISTRATION PROBE COULD UPEND WIDELY USED TRANSGENDER YOUTH TREATMENT GUIDELINES
A transgender rights supporter takes part in a rally outside the U.S. Supreme Court as the justices hear arguments in a case on transgender health rights in Washington, D.C., on Dec. 4, 2024.(Kevin Dietsch/Getty Images)
“So they agree that the decision about healthcare ought to be between the person and their provider. That’s it. So let’s use that standard, and keep to that standard, and make sure the government doesn’t have the ability to tell you what you can or cannot do with your own life,” El-Sayed said.
However, the research on the efficacy of treating individuals with gender dysphoria by allowing them to change sexes with “cross-sex” hormones and puberty blockers is limited.
The World Professional Association for Transgender Health, whose guidelines are used by leading medical associations like the American Academy of Peditatrics, is currently facing a lawsuit from the Federal Trade Commission stemming from allegations that its guidelines misled parents about the “medical consensus and medical necessity, as well as the safety and effectiveness” of sex change procedures.
The FTC has accused WPATH of failing to disclose the side effects associated with some procedures, such as patients experiencing incontinence, erectile pain, mood disturbances, pelvic pain and vaginal pain stemming from “cross-sex” hormones.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Meanwhile, countries that have socialized medicine have put restrictions in place for minors seeking sex changes. In England, the National Health Service put a pause on “cross-sex” hormones for 16- and 17-year-olds in March after finding research was “really weak” to support it.
The country already had a ban in place restricting children under 16 years old from taking sex-change hormones.
El-Sayed’s office did not immediately respond to Fox News Digital’s request for comment regarding his medical credentials.
Elaine Mallon is a writer for Fox News Digital and Fox Business covering national politics.
https://www.foxnews.com/video/6404973816112
blob:https://www.foxnews.com/3a0d4f57-e564-4368-be7e-216b30dd36ee
发表回复